Rainbow (Biotechnology) Overview
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.51M
- Investors
-
13
Rainbow (Biotechnology) General Information
Description
Developer of an autologous bone marrow mesenchymal stem cell product designed to treat cerebral infarction. The company's product is directly administered to the area around cerebral infarction, enabling clinicians with regenerative medicine to treat neurological and vascular diseases.
Contact Information
Website
www.rainbowinc.co.jpCorporate Office
- 1st Floor, HX, HokkaidoKita Ward, Sapporo CityKita 21-jo Nishi 11-chome
- Hokkaido University Food & Medical Innovation International Center, Kita-ku
- Sapporo, Kita-ku 001-0021
- Japan
Corporate Office
- 1st Floor, HX, HokkaidoKita Ward, Sapporo CityKita 21-jo Nishi 11-chome
- Hokkaido University Food & Medical Innovation International Center, Kita-ku
- Sapporo, Kita-ku 001-0021
- Japan
Rainbow (Biotechnology) Timeline
Rainbow (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 29-May-2026 | $1.51M | Completed | Generating Revenue | ||
| 5. Early Stage VC | 29-Sep-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 17-Nov-2020 | Completed | Clinical Trials - Phase 2 | |||
| 3. Early Stage VC (Series A) | 26-Oct-2020 | Completed | Clinical Trials - Phase 1 | |||
| 2. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 1. Corporate | 01-Nov-2018 | Completed | Clinical Trials - Phase 1 |
Rainbow (Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| C Preferred | ||||||||
| B Preferred | ||||||||
| A preferred | 200 | $4743.01 | $4743.01 | 1x | $4743.01 | 11.45% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Rainbow (Biotechnology) Signals
Rainbow (Biotechnology) Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AKK (Japan) | Venture Capital | Minority | ||
| Crypton Future Media Inc. | Corporation | Minority | ||
| Higin Capital | Investment Bank | Minority | ||
| Medical System Network | Corporation | Minority | ||
| S&S (Japan) | Venture Capital | Minority |
Rainbow (Biotechnology) FAQs
-
Where is Rainbow (Biotechnology) headquartered?
Rainbow (Biotechnology) is headquartered in Sapporo, Japan.
-
What is the size of Rainbow (Biotechnology)?
Rainbow (Biotechnology) has 8 total employees.
-
What industry is Rainbow (Biotechnology) in?
Rainbow (Biotechnology)’s primary industry is Biotechnology.
-
Is Rainbow (Biotechnology) a private or public company?
Rainbow (Biotechnology) is a Private company.
-
What is the current valuation of Rainbow (Biotechnology)?
The current valuation of Rainbow (Biotechnology) is .
-
What is Rainbow (Biotechnology)’s current revenue?
The current revenue for Rainbow (Biotechnology) is .
-
How much funding has Rainbow (Biotechnology) raised over time?
Rainbow (Biotechnology) has raised $4.75M.
-
Who are Rainbow (Biotechnology)’s investors?
AKK (Japan), Crypton Future Media Inc., Higin Capital, Medical System Network, and S&S (Japan) are 5 of 13 investors who have invested in Rainbow (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process